Fabino Life Sciences Ltd

Fabino Enterprises Ltd (formerly Fabino Life Sciences Limited) announced the approval of audited standalone and consolidated financial results for the year ended March 31, 2026, during its board meeting held on May 23, 2026. The results comply with accounting standards and include statements of assets, liabilities, and cash flow. The board meeting commenced at 5:30 P.M. and concluded at 6:30 P.M. The Independent Auditors Report with unmodified opinion is enclosed as Annexure A.

Fabino Enterprises Ltd has scheduled a Board of Directors meeting on May 23, 2026, to consider and approve the audited financial results (standalone and consolidated) for the half year and year ended March 31, 2026. The meeting will be held at the company's registered office in Sonipat, Haryana. The trading window for dealing in the company's securities is currently closed and will reopen 48 hours after the board meeting's outcome is declared.

Aryaman Financial Services Ltd, the manager to the offer, has submitted a Draft Letter of Offer to BSE for the acquisition of 5,46,000 equity shares of Fabino Enterprises Ltd, constituting 26% of the equity share capital. The open offer is made by R G Family Trust, Sameer Gupta, and Sundeep Gupta at a price of ₹20 per fully paid-up equity share, payable in cash. The offer is unconditional and subject to applicable statutory approvals.

Aryaman Financial Services Ltd, the manager to the offer, has announced an open offer for the acquisition of 5,46,000 equity shares of Fabino Enterprises Ltd, constituting 26% of the equity share capital. The acquirers are R G Family Trust, Sameer Gupta, and Sundeep Gupta. This offer complies with SEBI regulations and is detailed in a public statement published on May 6, 2026, in multiple newspapers.

R G Family Trust, Sameer Gupta, and Sundeep Gupta (Acquirers) have made a public announcement for an open offer to acquire 5,46,000 equity shares of Fabino Enterprises Limited, representing 26.00% of the company's fully diluted equity share capital. The offer price is ₹20 per share, amounting to a total consideration of ₹109.20 Lakhs. This open offer was triggered by an underlying Share Purchase Agreement dated April 28, 2026, where the Acquirers agreed to acquire 11,93,200 equity shares (56.82% shareholding) from existing sellers for ₹214.78 Lakhs, leading to a direct acquisition of majority voting rights and control over the Target Company.

Sushma Shekhar has filed a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, reporting the acquisition of 174,000 equity shares of Fabino Enterprises Ltd. This acquisition, conducted through the open market, represents an 8.29% stake in the target company's total share and voting capital. Sushma Shekhar is not identified as belonging to the promoter or promoter group. The total equity share capital of Fabino Enterprises Ltd. remains INR 2,10,00,000, comprising 2,100,000 equity shares of INR 10 each, both before and after this transaction. Notably, the reported date of acquisition is 09-04-2026, which is an unusual future date for a disclosure concerning a completed acquisition.

Fabino Enterprises Ltd has announced the closure of the trading window for dealing in securities of the company. The closure is in accordance with the Company's Code for prevention of Insider Trading under SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will be closed for designated persons of the company and their immediate relatives, starting from Wednesday, 1st April, 2026 until 48 hours after the announcement of the Audited Financial Results for the year ended 31st March, 2026. The date of the Board Meeting for the consideration and approval of the Financial Results will be communicated in due course.

Fabino Enterprises Ltd has appointed Mrs. Deepali Singla as an Additional (Non-Executive) Independent Director. This appointment is subject to the approval of the company's shareholders. The company has also accepted the resignation of Mr. Kuldeep Solanki from his position as an Independent Director. The resignation is effective immediately.

Fabino Enterprises Ltd has announced the resignation of Mr. Kuldeep Solanki as a Non-Executive Independent Director, effective immediately. The resignation was received on December 26, 2025. The Company will address the succession at the upcoming Board meeting. Mr. Solanki has provided a confirmation that there are no other material reasons for his resignation beyond those mentioned in his resignation letter.

Fabino Enterprises Ltd, an ISO 9001:2015 Certified Company (formerly known as Fabino Life Sciences Ltd.), has announced the appointment of Mrs. Deepali Singla as an Additional Non-Executive Director designated as Independent Director. The appointment is subject to the approval of the shareholders of the Company. Mrs. Singla, who is currently an Associate at United Lex, has over 6 years of professional experience in document review, redactions for legal and regulatory matters, and strong expertise in corporate law, legal research, and drafting. She will serve until the ensuing General Meeting.